Overall, the findings in both PDAC and NPC suggest that the relationship between LIF-LIFR signaling, YES-YAP activity and the Hippo pathway are significantly more nuanced than originally described in breast cancer models. The gene discussed is LIF; the disease is breast carcinoma.